Top Markets
Coin of the day
Valerio Therapeutics S.A. Valerio Therapeutics S.A.

Valerio Therapeutics S.A.

ALVIO
Rang în acțiuni #14050
Headquartered in Paris, France, and founded in 1997, Valerio Therapeutics S.A.... Headquartered in Paris, France, and founded in 1997, Valerio Therapeutics S.A. (known as Onxeo SA until June 2023) is a clinical-stage biotechnology company dedicated to the global research and development of oncology treatments. Their focus is on targeting the DNA repair processes crucial for tumor survival. The company's offerings include Beleodaq, an approved medication for peripheral T-cell lymphoma. Their development pipeline features AsiDNA, which is progressing through Phase 1 clinical trials for metastatic melanoma and is also being evaluated for relapsed ovarian cancer through a research collaboration with Gustave Roussy. Furthermore, Valerio Therapeutics is advancing OX401, a preclinical program targeting DNA damage response and immuno-oncology, along with its proprietary platON decoy oligonucleotide platform. The firm also holds a licensing agreement with Acrotech Biopharma LLC.
Preț acțiune
$0.88012714
Ultima sincronizare: 2026-08-31
Capitalizare de piață
$439.58M
Schimbare (1 zi)
-4.01%
Schimbare (1 an)
1,131.97%
Țară
FR
Tranzacționează Valerio Therapeutics S.A. (ALVIO)

Categorie

Istoric al prețului acțiunii pentru Valerio Therapeutics S.A. (ALVIO)
Cel mai mare preț de închidere: $0.91 pe 2026-08-01

Cel mai mic preț de închidere: $0.28 pe 2023-06-01
Istoric al prețului acțiunii pentru Valerio Therapeutics S.A. din 2023 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2026 (TTM) 53.06%
2025 116.87%
2024 -58.47%
2023 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
$544.38 39.22%
US
$1.03K 45.21%
NL
$122.88 -10.84%
AU
$138.80 476.17%
US
$749.90 5.10%
CH